0001127602-18-011413.txt : 20180313
0001127602-18-011413.hdr.sgml : 20180313
20180313172035
ACCESSION NUMBER: 0001127602-18-011413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180312
FILED AS OF DATE: 20180313
DATE AS OF CHANGE: 20180313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEISS ROBERT S
CENTRAL INDEX KEY: 0001181959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08597
FILM NUMBER: 18687413
MAIL ADDRESS:
STREET 1: 6140 STANERIDGE MALL RES #590
CITY: PLEASSANTON
STATE: CA
ZIP: 94503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COOPER COMPANIES INC
CENTRAL INDEX KEY: 0000711404
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 942657368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 6140 STONERIDGE MALL RD
STREET 2: STE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
BUSINESS PHONE: 9254603600
MAIL ADDRESS:
STREET 1: 6140 STONERIDGE MALL ROAD
STREET 2: SUITE 590
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER COMPANY:
FORMER CONFORMED NAME: COOPERVISION INC
DATE OF NAME CHANGE: 19870701
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-12
0000711404
COOPER COMPANIES INC
COO
0001181959
WEISS ROBERT S
6140 STONERIDGE MALL ROAD
SUITE 590
PLEASANTON
CA
94588
1
1
President & CEO
Common Stock
2018-03-12
4
M
0
36769
95.74
A
135936
D
Common Stock
2018-03-12
4
S
0
8431
241.57
D
127505
D
Common Stock
2018-03-12
4
S
0
27209
242.57
D
100296
D
Common Stock
2018-03-12
4
S
0
1129
242.99
D
99167
D
Common Stock
46453
I
Robert S. Weiss and Marilyn A. Weiss, Trustees of the Robert and Marilyn Weiss Trust dated 5/17/06
Employee Stock Option (Right to Buy)
95.74
2018-03-12
4
M
0
36769
0
D
2022-12-11
Common Stock
36769
0
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.97 to $241.965. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
The sales price represents a weighted average of sales prices ranging between $241.97 and $242.965.
The sales price represents a weighted average of sales prices ranging between $242.97 and $243.02.
12/12/12 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/12/13; 1/5 shall vest on 12/12/14; 1/5 shall vest on 12/12/15; 1/5 shall vest on 12/12/16; and 1/5 shall vest on 12/12/17.
/s/ Robert S. Weiss
2018-03-13